SCHEDULE 13D/A Filed 2026-08-14 Event 2026-06-30 SEC 0001193125-26-352656 →

PERCEPTIVE ADVISORS LLC → Solid Biosciences Inc. SLDB

Stake: — Shares: 12,046,579 Class: Common Stock, $0.001 par value per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

21 13D/G filings on this issuer

20 other filings besides this one

Filer Track Record

30 filings by this filer

29 other filings in the data moat

Short Interest · settle 2026-07-31

DTC 16.21

17,036,347 shares short · -3.6% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $13.63M

Point72 Asset Mgmt

Other 13D/G Filings on Solid Biosciences Inc.

Filed	Form	Filer	Stake	Shares
2026-06-24	SCHEDULE 13D/A	RA CAPITAL MANAGEMENT, L.P.	—	12,036,126	view →
2025-02-21	SCHEDULE	PERCEPTIVE ADVISORS LLC	15.60%	11,934,679	view →
2025-02-21	SCHEDULE	RA CAPITAL MANAGEMENT, L.P.	9.90%	7,989,820	view →
2025-02-21	SCHEDULE	BCLS SB Investco, LP	7.80%	6,179,042	view →
2024-01-12	SC	BCLS SB Investco, LP	—	—	view →
2024-01-11	SC	RA CAPITAL MANAGEMENT, L.P.	—	—	view →
2024-01-10	SC	BCLS SB Investco, LP	—	—	view →
2022-12-06	SC	PERCEPTIVE ADVISORS LLC	—	—	view →
2022-12-05	SC	RA CAPITAL MANAGEMENT, L.P.	—	—	view →
2022-12-05	SC	BCLS SB Investco, LP	—	—	view →
2022-10-04	SC	RA CAPITAL MANAGEMENT, L.P.	—	—	view →
2022-10-03	SC	BCLS SB Investco, LP	—	—	view →
2021-03-25	SC	BCLS SB Investco, LP	—	—	view →
2021-03-23	SC	PERCEPTIVE ADVISORS LLC	—	—	view →
2021-03-23	SC	RA CAPITAL MANAGEMENT, L.P.	—	—	view →
2020-12-17	SC	PERCEPTIVE ADVISORS LLC	—	—	view →
2020-12-16	SC	RA CAPITAL MANAGEMENT, L.P.	—	—	view →
2020-12-11	SC	BCLS SB Investco, LP	—	—	view →
2019-07-30	SC	RA CAPITAL MANAGEMENT, LLC	—	—	view →
2019-07-30	SC	BCLS SB Investco, LP	—	—	view →

Other Filings by PERCEPTIVE ADVISORS LLC

Filed	Form	Issuer	Stake	Shares
2026-08-14	SCHEDULE 13D/A	Nautilus Biotechnology, Inc.	—	11,634,211	view →
2026-07-23	SCHEDULE 13G	Freenome, Inc.	—	—	view →
2026-07-20	SCHEDULE 13G	Research Alliance Corporation IV	—	—	view →
2026-06-25	SCHEDULE 13D	Kardigan, Inc. KARD	8.90%	8,254,144	view →
2026-01-26	SCHEDULE	TRINITY BIOTECH PLC TRIB	9.90%	1,463,058,248	view →
2026-01-02	SCHEDULE	MeiraGTx Holdings plc MGTX	12.90%	10,441,562	view →
2025-02-21	SCHEDULE	Solid Biosciences Inc. SLDB	15.60%	11,934,679	view →
2025-02-14	SCHEDULE	TRINITY BIOTECH PLC TRIB	20.90%	85,800,000	view →
2025-01-31	SCHEDULE	Nautilus Biotechnology, Inc. NAUT	10.00%	12,594,211	view →
2023-10-17	SC	Cerevel Therapeutics Holdings, Inc.	—	—	view →
2023-06-06	SC	SOLENO THERAPEUTICS INC SLNO	—	—	view →
2023-05-30	SC	SOLENO THERAPEUTICS INC SLNO	—	—	view →
2023-05-25	SC	SOLENO THERAPEUTICS INC SLNO	—	—	view →
2023-04-25	SC	Cerevel Therapeutics Holdings, Inc.	—	—	view →
2022-12-06	SC	Solid Biosciences Inc. SLDB	—	—	view →
2022-07-01	SC	Athira Pharma, Inc. LONA	—	—	view →
2022-04-14	SC	Lyra Therapeutics, Inc. LYRA	—	—	view →
2022-03-02	SC	AMICUS THERAPEUTICS, INC. FOLD	—	—	view →
2021-06-25	SC	CATABASIS PHARMACEUTICALS INC	—	—	view →
2021-04-06	SC	Landos Biopharma, Inc.	—	—	view →

Showing 20 of 29

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →